EMEA-001071-PIP02-12-M02

Key facts

Invented name
Cimzia
Active substance
Certolizumab pegol
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0192/2017
PIP number
EMEA-001071-PIP02-12-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of chronic idiopathic arthritis (including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and juvenile idiopathic arthritis)
Route(s) of administration
Subcutaneous use
Contact for public enquiries
UCB Pharma S.A.

E-mail: medinfone@ucb.com
Tel. +32 2559 9999

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating